Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know

Group 1 - Inspire Medical Systems (INSP) has shown a significant price increase of 14.5% over the past four weeks, with a mean price target of $225.07 indicating a potential upside of 39% from the current price of $161.88 [1] - The average of 15 short-term price targets ranges from a low of $175 to a high of $270, with a standard deviation of $26.91, suggesting a variability in analysts' estimates [2] - Analysts have revised earnings estimates higher, with seven estimates moving up in the last 30 days and no negative revisions, leading to a 3.7% increase in the Zacks Consensus Estimate [12] Group 2 - INSP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - There is a strong correlation between trends in earnings estimate revisions and near-term stock price movements, supporting the expectation of an upside in INSP [11] - Analysts' price targets, while often overly optimistic, can provide a starting point for further research into the stock's potential [9][10]